Zevra Therapeutics

We are a commercial-stage company committed to redefining what is possible in bringing life-changing therapies to people living with rare diseases.
$ZVRA

[Zevra Therapeutics @zevratx]

Behind every rare disease journey is often a caregiver providing strength, advocacy, and unwavering support.
To all caregivers: your dedication makes a profound difference.
#Caregivers #RareDisease #PatientAdvocacy #CaregiverSupport #RareDiseaseCommunity

[Zevra Therapeutics @zevratx]

Thanks to the Termeer Institute for hosting a great networking session & panel discussion on Building Impactful Teams & Culture. We were proud to have our Chief People Officer, Alison Peters share insights on building strong teams & fostering a culture where people can thrive.

[Zevra Therapeutics @zevratx]

Our President & CEO will present at 2 upcoming investor conferences:
Morgan Stanley Annual Global Healthcare Conference
🗓️ Sept 14, 2026
🕔 5:35 pm ET
H.C. Wainwright Annual Global Investment Conference
🗓️ September 15, 2026
🕙 10 am ET
Register here: https://t.co/J2yFLyC5gh

[Zevra Therapeutics @zevratx]

September is #NewbornScreeningAwarenessMonth.

At Zevra, we recognize the difference earlier diagnosis can make for families affected by NPC & other rare diseases.

We’re proud to support efforts to expand newborn screening & help more families find answers sooner.

#RareDisease

[Zevra Therapeutics @zevratx]

Join our President and CEO, Neil McFarlane, as he shares company updates at the Cantor Global Healthcare Conference.

🗓️ September 9, 2026
🕘 9:10 a.m. ET

Register for the webcast presentation here: https://t.co/J2yFLyBxqJ

[Zevra Therapeutics @zevratx]

This Labor Day, we're grateful for the healthcare professionals, researchers, caregivers, advocates, and employees whose dedication helps advance care for people living with rare diseases.

Thank you for all you do. Wishing everyone a safe and restful holiday.
#LaborDay

[Zevra Therapeutics @zevratx]

At Zevra, we're united by one purpose: improving the lives of people living with rare diseases.
Every role, every project, and every milestone starts with patients and families.
#RareDisease #PatientCentricity

[Zevra Therapeutics @zevratx]

Thank you to the SSIEM attendees for an engaging and impactful meeting focused on advancing care for people living with rare metabolic diseases, including Niemann-Pick disease type C (NPC).

#SSIEM2026 #RareDisease #NPC

[Zevra Therapeutics @zevratx]

We’re presenting two posters featuring new real-world data on arimoclomol in Niemann-Pick disease type C (NPC) during a dedicated poster walk on Wed. August 26, from 5:30–6:30 pm CEST at SSIEM 2026.

Read the press release: https://t.co/5c26h4cxkt

#SSIEM2026 #RareDisease #NPC

[Zevra Therapeutics @zevratx]

We’re heading to SSIEM 2026 and are excited to present new real-world data on arimoclomol in people living with Niemann-Pick disease type C (NPC).

Visit us at booth S12 in exhibition hall 5 to learn more!

#SSIEM2026 #RareDisease #NPC

[Zevra Therapeutics @zevratx]

Did you know Niemann-Pick disease type C (NPC) can affect both children and adults?

Because NPC is rare, diagnosis can be challenging. Greater awareness can potentially help families find answers sooner.

Learn about NPC signs, symptoms, & resources: https://t.co/G4d0AJrjeS

[Zevra Therapeutics @zevratx]

Honored that Zevra has been nominated for the 2026 Prix Galien USA Awards in the Best Product for Rare/Orphan Diseases category. This recognition reflects our commitment to advancing meaningful therapies for people living with rare diseases. #PrixGalienUSA #RareDisease

[The Galien Foundation @GalienFdn]

𝗣𝗿𝗶𝘅 𝗚𝗮𝗹𝗶𝗲𝗻 𝟮𝟬𝟮𝟲 𝗻𝗼𝗺𝗶𝗻𝗲𝗲𝘀 𝗼𝗳𝗳𝗶𝗰𝗶𝗮𝗹 𝘀𝗲𝗹𝗲𝗰𝘁𝗶𝗼𝗻 𝗮𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝗱!
See the 2026 #PrixGalien USA nominees for Best Biotech, Best Pharma & Best Product for Rare/Orphan Diseases. Read more: https://t.co/YT67wv52T3

[Zevra Therapeutics @zevratx]

Our President and CEO Neil McFarlane will share the latest company updates in a fireside chat at the CG 46th Annual Growth Conference today, August 11, 2026 at 11:00 am ET.

Register for the webcast presentation here: https://t.co/J2yFLyBxqJ

[Zevra Therapeutics @zevratx]

$ZVRA reports second quarter 2026 financial results and provides a corporate update.

Join our LIVE webcast TODAY at 4:30 p.m. ET: https://t.co/01ooavaQAx

For more, find the full release here: https://t.co/RIfePDFIIV
#RareDiseases #InvestorRelations #IR

[Zevra Therapeutics @zevratx]

We’re pleased to announce the publication of “Long-term Real-World Safety and Effectiveness of Arimoclomol in Individuals with NPC: Outcomes from the U.S. Early Access Program Over a 4-Year Period.”

Read our press release to learn more: https://t.co/eHgu5eQ01Z

[Zevra Therapeutics @zevratx]

On #GeneticTestingActionDay, we recognize the power of genetic testing to help people with rare diseases, like NPC, get answers sooner. At Zevra, we're committed to raising awareness and working to help shorten the path to diagnosis.

#RareDisease #GeneticTesting

[Zevra Therapeutics @zevratx]

$ZVRA will report second quarter 2026 financial results & provide a corporate update on Wednesday, August 5, 2026, with a live webcast at 4:30 p.m. ET.

For registration details, see the release: https://t.co/5jy6XhqOMw

[Zevra Therapeutics @zevratx]

July is Disability Pride Month. Many people living with NPC experience disabilities that impact daily life. This month, we recognize the strength & resilience of the NPC community & reaffirm the importance of inclusion, accessibility, & amplifying patient voices.

#RareDisease

[Zevra Therapeutics @zevratx]

Thank you, NNPDF, for a meaningful conference.
It was rewarding to connect with NPC families & hear firsthand perspectives from the community.

We're grateful for the conversations& shared commitment to supporting those affected by Niemann-Pick disease type C.
#NNPDF #RareDisease

[Zevra Therapeutics @zevratx]

We're excited to attend the @nnpdf Family Support & Medical Conference!

We look forward to engaging with the community, learning from their experiences, and participating in important conversations about the future of NPC care and support.

#NNPDF #RareDisease